Advertisement

Neurotransmitter Alterations in the Aging Brain

  • J. Rogers
  • W. J. Shoemaker
  • F. E. Bloom

Abstract

This review of neurotransmitter alterations in aging brain is intended to focus on studies of human and animal material where one or more measurements were made of these special brain substances. There are several reasons to study neurotransmitter substances in aging nervous system: 1. neurotransmitters provide the means for communication between neurons in the CNS, and therefore, play a key role in the efficient processing of sensory, motor and integrative neural signals, as well as controlling the endocrine systems of the body [68–70]; 2. the loss of a particular neurotransmitter, dopamine, shows a strong correlation with age in man and animals, and is etiological for the age-related disease, Parkinsonism; 3. the means for detecting transmitters are easily adapted for quantitative analysis, allowing age vs transmitter level correlations, and 4. the potential for pharmacological intervention on brain aging is based, in part, on the known structure and metabolism of the neurotransmitters [41, 46].

Keywords

Luteinizing Hormone Vasoactive Intestinal Polypeptide Aging Brain Senile Dementia Choline Uptake 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Abbey H (1979) Survival characteristics of mouse strains. In: Gibson DC, Adelman RC, Finch CE (eds) Development of the rodent as a model system of aging. U.S. Government Printing Office, Washington D.C., DHEW Publication No. (NIH), pp 79–161Google Scholar
  2. 2.
    Adolfsson R, Gottfries CG, Roos BE, Winblad B (1979) Postmortem distribution of dopamine and homovanillic acid in human brain, variations related to age, and a review of the literature. J Neural Transm 45, p 81PubMedCrossRefGoogle Scholar
  3. 3.
    Aghajanian GK, Rosecrans JA, Sheard MH (1967) Serotonin: Release in the forebrain by stimulation of the midbrain raphe. Science 156, p 402PubMedCrossRefGoogle Scholar
  4. 4.
    Algeri S, Bonati M, Brunello N, Ponzio F (1977) Dihydropteridine reductase and tyrosin hydroxylase activities in rat brain during development and senescence: a comparative study. Brain Res 132, p 569PubMedCrossRefGoogle Scholar
  5. 5.
    Algeri S, Ponzio F, Bonati M, Brunello N (1976) Biochemical changes in monoaminergic nerves in the CNS of the senescent rat. Paper presented at Xth CINP meeting, Québec, CanadaGoogle Scholar
  6. 6.
    Azmitia EC, Quartermain D, Brennan MJ (1979) Hippocampal 3H-5HT uptake and behavioral change in young and aged mice. Exp Brain Res 36 ( Suppl ), R4Google Scholar
  7. 7.
    Barbeau A, Chase T, Paulson GW (1973) Advances in neurology, vol 1, Huntington’s Chorea, 1872–1972, In: Barbeau A, Chase T, Paulson GW (eds). Raven Press, New YorkGoogle Scholar
  8. 8.
    Barbeau A, Growdon JH, Wurtman RJ (1979) Nutrition and the brain, vol 5: Choline and lecithin in brain disorders. Raven Press, New YorkGoogle Scholar
  9. 9.
    Barden N, Dupont A, Labrie F, Merand Y, Rouleu D, Yaudry H, Boissier JR (1981) Age- dependent changes in the beta-endorphin content of discrete rat brain nuclei. Brain Res 208, p 209PubMedCrossRefGoogle Scholar
  10. 10.
    Barnes CA (1979) Memory deficits associated with senescence: A neurophysiological and behavioral study in the rat. J Comp Physiol Psychol 93, p 74PubMedCrossRefGoogle Scholar
  11. 11.
    Bartus RT (1979) Physostigmine and recent memory: Effects in young and aged nonhuman primates. Science 206, p 1087PubMedCrossRefGoogle Scholar
  12. 12.
    Bartus RT (1978) Evidence for a direct cholinergic involvement in the scopolamine-indueed amnesia in monkeys: Effects of concurrent administration of physostigmine and methyphen-idate with scopolamine. Pharm Biochem Behav 9. p 833CrossRefGoogle Scholar
  13. 13.
    Bartus RT, Dean RL, Beer B (1980) Memory deficits in aged cebus monkeys and facilitation with central cholinomimetics. Neurobiol Aging 1, p 145CrossRefGoogle Scholar
  14. 14.
    Bartus RT, Dean RL III, Beer B, Lippa AS (1982) The cholinergic hypothesis of geriatric memory disfunction. Science 217, p 408PubMedCrossRefGoogle Scholar
  15. 15.
    Bartus RT, Dean RL III, Sherman KA, Friedman E, Beer B (1981) Profound effects of combining choline and piracetam on memory enhancement and cholinergic function in aged rats. Neurobiol Aging 2, p 105PubMedCrossRefGoogle Scholar
  16. 16.
    Bartus RT, Dean RL, Goas J A, Lippa AS (1980) Age-related changes in passive avoidance retention: Modulation with dietary choice. Science 209, p 301PubMedCrossRefGoogle Scholar
  17. 17.
    Bartus RT, Johnson HR (1976) Short-term memory in the rhesus monkey: Disruption from the anti-cholinergie scopolamine. Pharm Biochem Behav 5, p 39CrossRefGoogle Scholar
  18. 18.
    Baudry M, Arst DS, Lynch G (1981) Increased [3H] glutamate receptor binding in aged rats. Brain Res 223, p 195PubMedCrossRefGoogle Scholar
  19. 19.
    Baudry M, Lynch G (1980) Hypothesis regarding the cellular mechanisms responsible for long-term synaptic potentation in the hippocampus. Exp Neurol 68, p 202PubMedCrossRefGoogle Scholar
  20. 20.
    Bayon A, Shoemaker WJ, McGinty J, Bloom FE (1982) Immunodetection of endorphins and enkephalins: A search for reliability. International review of neurobiology, vol 24, in pressGoogle Scholar
  21. 21.
    Benedetti MS, Keane PE (1980) Differential changes in monoamine oxidase A and B activity in the aging rat brain. J Neurochem 35, p 1026PubMedCrossRefGoogle Scholar
  22. 22.
    Berg A, Zimmerman ID (1975) Effects of electrical stimulation and norepinephrine on cyclic-AMP levels in the cerebral cortex of the aging rat. Mech Ageing Develop 4, p 377CrossRefGoogle Scholar
  23. 23.
    Bertler A (1961) Occurrence and localization of catecholamines in the human brain. Acta Physiol Scand 51, p 97CrossRefGoogle Scholar
  24. 24.
    Bhattacharyya AK, Pradhan SN (1980) Comparative effects of dopamine agonists in young and old rats. Fed Proc 39, p 508Google Scholar
  25. 25.
    Bird ED, Iversen LL (1974) Huntington’s chorea: Post-mortem measurement of glutamic acid decarboxylase, choline acetyltransferase and dopamine in basal ganglia. Brain 97, p 457PubMedCrossRefGoogle Scholar
  26. 26.
    Bird ED, Mackay A VP, Rayner CN, Iversen LL (1973) Reduced glutamie-acid-decarbox- ylase activity of post-mortem brain in Huntington’s chorea. Lancet 1, p 1090PubMedCrossRefGoogle Scholar
  27. 27.
    Bloom FE, McGinty JF (1981) Cellular distribution and function of endorphins. In: Endogenous peptides and learning and memory processes. Academic Press, New York, p 199Google Scholar
  28. 28.
    Boston Collaborative Drug Surveillance Program Report (1973) Clinical depression of the CNS due to diazepam and chlordiazepoxide in relation to cigarette smoking and age. N Engl J Med 288, p 277CrossRefGoogle Scholar
  29. 29.
    Bowen DM, Smith CB, White P, Davison AN (1976) Neurotransmitter-related indices of hypoxia in senile dementia and other abiotrophies. Brain 99, p 459PubMedCrossRefGoogle Scholar
  30. 30.
    Bowers MB, Gerbode FA (1968) Relationship of monoamine metabolites in human cerebrospinal fluid to age. Nature 219, p 1256PubMedCrossRefGoogle Scholar
  31. 31.
    Brennan MJ, Dallob A, Friedman E (1981) Involvement of hippocampal serotonergic activity in age-related changes in exploratory behavior. Neurobiol Aging 2, p 199PubMedCrossRefGoogle Scholar
  32. 32.
    Buck SH, Deshmukh PP, Burks TF, Yamamura HI (1981) A survey of substance P, somatostatin, and neurotensin levels in aging in the rat and human central nervous system. Neu-robiol Aging 2, p 257CrossRefGoogle Scholar
  33. 33.
    Burks TF, Buck SH, Yamamura HI, Deshmukh PP (1981) Level of substance P, somatostatin, and neurotensin in rodent and human CNS in aging. Age 4, p 143Google Scholar
  34. 34.
    Carlsson A, Adolfsson R, Aquilonius SM, Gottfries CG, Oreland L, Svennerholm L, Winblad B (1980) Biogenic amines in human brain in normal aging, senile dementia, and chronic alcoholism. In: Goldstein M, Lieberman A, Caine DB, Thorner MO (eds) Ergot compounds and brain function. Neuroendocrine and neuropsychiatric aspects. Raven Press, New York, p 295Google Scholar
  35. 35.
    Carlsson A, Winblad B (1976) The influence of age and time interval between death and autopsy on dopamine and 3-methoxytyramine levels in human basal ganglia. J Neural Transm 38, p 271PubMedCrossRefGoogle Scholar
  36. 36.
    Christe JE, Shering A, Ferguson J, Glen AIM (1981) Physostigmine and arecholine: Effects of intravenous infusions in Alzheimer presenile dementia. Brit J Psychiat 138, p 46CrossRefGoogle Scholar
  37. 37.
    Clark SM, Lipton JM (1981) Hypothermia produced in aged squirrel monkeys by central administration of taurine. Exp Aging Res 7, p 17PubMedCrossRefGoogle Scholar
  38. 38.
    Coleman GC, Barthold SW, Osbaldiston GW, Foster SJ, Jonas AM (1977) Pathological changes during aging in barrier-related Fischer 344 male rats. J Gerontol 32, p 258PubMedGoogle Scholar
  39. 39.
    Cooper JR, Bloom FE, Roth RH (1978) The biochemical basis of neuropharmacology. Oxford University Press, New York, p 225Google Scholar
  40. 40.
    Cooper RL, McNamara MC, Thompson WG (1980) Vasopressin and conditioned flavor aversion in aged rats. Neurobiol Aging 1, p 53PubMedCrossRefGoogle Scholar
  41. 41.
    Corkin S (1981) Acetylcholine, aging and Alzheimer’s disease. TINS 42, p 287Google Scholar
  42. 42.
    Corsellis JAN (1976) Some observations on the Purkinje cell population and on brain volume in human aging. In: Terry RD, Gershon S (eds) Neurobiology of aging. Raven Press, New York, p 205Google Scholar
  43. 43.
    Costa E, Meek J (1974) Regulation of the biosynthesis of catecholamines and serotonin in the CNS. Ann Rev Pharmacol 14, p 491CrossRefGoogle Scholar
  44. 44.
    Cote LJ, Kebabian TW (1978) Beta-adrenergic receptor in brain: Comparison of 3H-dihy- droalprenolol binding sites and a beta-adrenergic receptor regulating the adenyl cyclase activity in cell free homogenates. Life Sci 23, p 1703PubMedCrossRefGoogle Scholar
  45. 45.
    Cote LJ, Kremzner LT (1974) Changes in neurotransmitter systems with increasing age in human brain. Trans Am Soc Neurochem 5, p 83Google Scholar
  46. 46.
    Crook T, Gershon S (eds) (1981) Strategies for the development of an effective treatment for senile dementia. Mark Powley Associates, New Canaan, Connecticut, 322 pagesGoogle Scholar
  47. 47.
    Davies P (1978) Studies on the neurochemistry of central cholinergic systems in Alzheimer’s disease. In: Katzman R, Terry RD, Bick KL (eds) Alzheimer’s disease: Senile dementia and related disorders. Raven PreSs, New York, p 453Google Scholar
  48. 48.
    Davies P, Fiesullin S (1981) Postmortem stability of a-bungarotoxin binding sites in mouse and human brain. Brain Res 216, p 449PubMedCrossRefGoogle Scholar
  49. 49.
    Davies P, Verth AH (1977) Regional distribution of muscarinic acetylcholine receptor in normal and Alzheimer’s type dementia brains. Brain Res 138, p 385PubMedCrossRefGoogle Scholar
  50. 50.
    Davies P, Terry RD (1981) Cortical somatostatin-like immunoreactivity in cases of Alzheimer’s disease and SDAT. Neurobiol Aging 2, p 9PubMedCrossRefGoogle Scholar
  51. 51.
    Davis KL, Berger PA (1979) Brain acetylcholine and neuropsychiatric disease. Plenum Press, New YorkCrossRefGoogle Scholar
  52. 52.
    Davis KL, Mohs RC, Tinklenberg JR (1979) Enhancement of memory by physostigmine. N Engl J Med 301, p 946PubMedGoogle Scholar
  53. 53.
    Davis KL, Yamamura HI (1978) Cholinergic underactivity in human memory disorders. Life Sci 23, p 1729PubMedCrossRefGoogle Scholar
  54. 54.
    De Koning-Verest IF (1980) Glutamate metabolism in ageing rat brain. Mech Ageing Develop 13, p 83CrossRefGoogle Scholar
  55. 55.
    Demarest KT, Moore KE, Riegle GD (in press) Dopaminergic neuronal function, anterior pituitary dopamine content, and serum concentrations of prolactin, luteinizing hormone and progesterone in the aged female rat. Brain ResGoogle Scholar
  56. 56.
    Demarest KT, Riegle GD, Moore KE (1980) Characteristics of dopaminergic neurons in the aged male rat. Neuroendocrinology 31, p 222PubMedCrossRefGoogle Scholar
  57. 57.
    Deutsch JA (1973) The cholinergic synapse and the site of memory. In: Deutsch JA (ed) The physiological basis of memory. Academic Press, New York, p 59Google Scholar
  58. 58.
    Diaz PM, Ngai SH, Costa E (1968) Factors modulating brain serotonin turnover. In: Costa E, Sandler M (eds) Advances in pharmacology, vol 6, part B. Academic Press, New York, p75Google Scholar
  59. 59.
    Drachman DA, Leavitt JL (1974) Human memory and the cholinergic system. A relationship to aging? Arch Neurol 30, p 113PubMedGoogle Scholar
  60. 60.
    Drachman DA (1977) Memory and cognitive function in man: Does the cholinergic system have a specific role? Neurology 27, p 783PubMedGoogle Scholar
  61. 61.
    Drachman DA, Sahakian BJ (1980) Memory and cognitive function in the elderly: A preliminary trial of physostigmines. Arch Neurol 37, p 674PubMedGoogle Scholar
  62. 62.
    Drachman DA, Noffsinger D, Sahakian BJ, Kurdzeil S, Fleming P (1980) Aging, memory and the cholinergic system: A study of dichotic listening. Neurobiol Aging 1, p 39PubMedCrossRefGoogle Scholar
  63. 63.
    Enna SJ, Bird ED, Bennet JP, Bylund DB, Yamamura HI, Iversen LL, Snyder SH (1976) Huntington’s chorea: Changes in neurotransmitter receptors in the brain. N Engl J Med 294, p 1305PubMedCrossRefGoogle Scholar
  64. 64.
    Enna SJ, Strong R (1981) Age-related alterations in CNS neurotransmitter receptor binding. In: Enna S, Samorajski T, Beer B (eds) Brain neurotransmitters and receptors in aging and age-related disorders. Raven Press, New York, p 133Google Scholar
  65. 65.
    Epstein MH, Barrows CH Jr (1969) The effects of age on the activity of glutamic acid decarboxylase in various regions of the brains of rats. J Gerontol 24, p 136PubMedGoogle Scholar
  66. 66.
    Estes KS, Simpkins JW (1980) Age-related alterations in catecholamine concentrations in discrete preoptic area and hypothalamic regions in the male rat. Brain Res 194, p 556PubMedCrossRefGoogle Scholar
  67. 67.
    Finch CE, Potter DE, Kenny AD (1978) Advances in experimental medicine and biology. In: Finch CE, Potter DE, Kenny AD (eds) Parkinson’s disease-II, vol 113. Plenum Press, New YorkGoogle Scholar
  68. 68.
    Finch CE (1973) Catecholamine metabolism in the brains of aging male mice. Brain Res 52, p 261PubMedCrossRefGoogle Scholar
  69. 69.
    Finch CE (1976) The regulation of physiological changes during mammalian aging. Quart Rev Biol 51, p 49PubMedCrossRefGoogle Scholar
  70. 70.
    Finch CE (1977) Neuroendocrine and autonomic aspects of aging. In: Finch CE, Hayflick I (eds) Handbook of the biology of aging. Van Nostrand Reinhold, New York, p 262Google Scholar
  71. 71.
    Finch CE (1978) Age-related changes in brain catecholamines: A synopsis of findings in C57BL/6J mice and the rodent models. In: Finch CE, Potter DE, Kenny AD (eds) Advances in experimental medicine and biology, vol 113: Parkinson’s disease-II. Plenum Press, New York, p 15Google Scholar
  72. 72.
    Finch CE (1980) The relationships of aging changes in the basal ganglia to manifestations of Huntington’s chorea. Ann Neurol 7, p 406PubMedCrossRefGoogle Scholar
  73. 73.
    Fonda ML, Acree DW, Auerbach SB (1973) The relationships of gamma-aminobutyrate levels and its metabolism to age in brains of mice. Arch Biochem Biophys 159, p 622CrossRefGoogle Scholar
  74. 74.
    Forman LJ, Sonntag WE, Van Vugt DA, Meites J (1981) Immunoreactive ß-endorphin in the plasma, pituitary and hypothalamus of young and old male rats. Neurobiol Aging 2, p 281PubMedCrossRefGoogle Scholar
  75. 75.
    Friede RL, Magee KR (1962) Alzheimer’s disease. Neurology 12, p 213PubMedGoogle Scholar
  76. 76.
    Friede RL (1965) Enzyme histochemical studies of senile plaques. J Neuropathol Exp Neurol 24, p 477CrossRefGoogle Scholar
  77. 77.
    Friedman E, Sherman KA, Ferris SH, Reisberg B, Bartus RT, Schneck MK (1981) Clinical response to choline plus piracetam in senile dementia: Relation to red-cell choline levels. N Engl J Med 304, p 1490PubMedCrossRefGoogle Scholar
  78. 78.
    Gambert SR (1981) Interaction of age and thyroid hormone status on β-endorphin content in rat corpus striatum and hypothalamus. Neuroendocrinology 32, p 114PubMedCrossRefGoogle Scholar
  79. 79.
    Gambert SR, Garthwaite TL, Pontzer CH, Hagen TC (1980) Age-related changes in CNS -endorphin and ACTH. Neuroendocrinology 31, p 252PubMedCrossRefGoogle Scholar
  80. 80.
    Gibson DC, Adelman RC, Finch CE (1978) Development of the rodent as a model system of aging. U.S. Government Printing Office, Washington D.C., DHEW Publication no (NIH), pp 79–161Google Scholar
  81. 81.
    Gibson GE, Peterson C, Jenden DJ (1981) Brain acetylcholine synthesis declines with senescence. Science 213, p 674PubMedCrossRefGoogle Scholar
  82. 82.
    Gibson GE, Peterson C, Sansone J (1981) Neurotransmitter and carbohydrate metabolism during aging and mild hypoxia. Neurobiol Aging 2, p 165PubMedCrossRefGoogle Scholar
  83. 83.
    Gibson GE, Peterson C (1981) Regional acetylcholine metabolism in senescent mice. Age 4, p 143Google Scholar
  84. 84.
    Giudicelli Y, Pequerry R (1978) β-adrenergic receptors and catecholamine-sensitive adenylate cyclase in rat fat-cell membrane: Influence of growth, cell size and ageing. Eur J Biochem 90, p 413PubMedCrossRefGoogle Scholar
  85. 85.
    Goldman G, Coleman PD (1981) Neuron numbers in locus coeruleus do not change with age in Fisher 344 rat. Neurobiol Aging 2, p 33PubMedCrossRefGoogle Scholar
  86. 86.
    Gottfries CS, Gottfries I, Johansson B, Olsson R, Persson T, Roos BE, Sjostrom R (1971) Acid monoamine metabolites in human cerebrospinal fluid and their relations to age and sex. Neuropharm 10, p 665CrossRefGoogle Scholar
  87. 87.
    Govoni S, Loddo P, Spano PF, Trabucchi M (1977) Dopamine receptor sensitivity in brain and retina of rats during aging. Brain Res 138, p 565PubMedCrossRefGoogle Scholar
  88. 88.
    Govoni S, Memo M, Saiani L, Spano PF, Trabucchi M (1980) Impairment of brain neurotransmitter receptors in aged rats. Mech Ageing Develop 12, p 39CrossRefGoogle Scholar
  89. 89.
    Greenberg LH, Weiss B (1978) Beta-adrenergic receptors in aged rat brain: Reduced number and capacity of pineal gland to develop supersensitivity. Science 201, p 61PubMedCrossRefGoogle Scholar
  90. 90.
    Greenberg LH, Weiss B (1979) Ability of aged rats to alter beta adrenergic receptors of brain in response to repeated administration of reserpine and desmethylimipramine. J Pharmacol Exp Ther 211, p 309PubMedGoogle Scholar
  91. 91.
    Grote SS, Moses SG, Robins E, Hudgens RW, Croninger AB (1974) A study of selected catecholamine-metabolizing enzymes: A comparison of depressive suicides and alcoholic suicides with controls. J Neurochem 23, p 791PubMedCrossRefGoogle Scholar
  92. 92.
    Haycock JW, White WF, McGaugh JL, Cotman CW (1977) Enhanced stimulus-secretion coupling from brains of aged mice. Exp Neurol 57, p 873PubMedCrossRefGoogle Scholar
  93. 93.
    Hess GD, Joseph J A, Roth GS (1981) Effects of age on sensitivity to pain and brain opiate receptors. Neurobiol Aging 2, p 49PubMedCrossRefGoogle Scholar
  94. 94.
    Hicks P, Rolsten C, Hsu L, Schoolar J, Samorajski T (1979) Brain uptake index for choline in aged rats. Soc Neurosci Abstr. 5, p 6Google Scholar
  95. 95.
    Hoffman GE, Sladek JR Jr (1980) Age-related changes in dopamine, LHRH and somatostatin in the rat hypothalamus. Neurobiol Aging 1, p 27PubMedCrossRefGoogle Scholar
  96. 96.
    Hornykiewicz O (1974) Abnormalities of nigrostriatal dopamine metabolism: Neurochemical, morphological and clinical correlations. J Pharmacol 5 [Suppl], p 64Google Scholar
  97. 97.
    Huang HH, Simpkins JW, Meites J (1977) Hypothalamic norepinephrine (NE), dopamine (DA) turnover and relation to LH, FSH, and prolactin release in old female rats. Endocrinology [Suppl] 100, p 331CrossRefGoogle Scholar
  98. 98.
    Ingram DK, London ED, Goodrick CL (1981) Age and neurochemical correlates of radial maze performance in rats. Neurobiol Aging 2, p 41PubMedCrossRefGoogle Scholar
  99. 99.
    James TC, Kanungo MS (1976) Alterations in atropine sites of the brain of rats as a function of age. Biochem Biophys Res Commun 72, p 170PubMedCrossRefGoogle Scholar
  100. 100.
    Jonec VJ, Finch CE (1975) Senescence and dopamine uptake by subcellular fractions of the C57BL/6J male mouse brain. Brain Res 91, p 197PubMedCrossRefGoogle Scholar
  101. 101.
    Joseph J A, Berger RE, Engel BT, Roth GS (1978) Age-related changes in the nigrostriatum: A behavioral and biochemical analysis. J Gerontol 33, p 643PubMedGoogle Scholar
  102. 102.
    Karnaukhov VN (1973) The role of carotenoids in the formation of lipofuscin and the adaptation of animal cells to oxygen insufficiency. Tsitologica 15, p 538Google Scholar
  103. 103.
    Karobath M, Placheta P, Lippitsch M, Krogsgaard-Larsen P (1980) Characterization of GABA-stimulated benzodiazepine receptor binding. In: Pepeu G, Kuhar MJ, Enna SJ (eds) Receptors for neurotransmitters and peptide hormones. Raven Press, New York, p 313Google Scholar
  104. 104.
    Katzman R, Terry RD, Bick KL (eds) (1978) Alzheimer’s disease: Senile dementia and related disorders. Raven Press, New YorkGoogle Scholar
  105. 105.
    Kubanis P, Zornetzer SF (1981) Age-related behavioral and neurobiological changes. A review with emphasis on memory. Behav Neural Biol 31, p 115PubMedCrossRefGoogle Scholar
  106. 106.
    Kumar MSA, Chen CL, Huang HH (1980) Pituitary and hypothalamic concentration of met-enkephalin in young and old rats. Neurobiol Aging 1, p 153CrossRefGoogle Scholar
  107. 107.
    Lai H, Gianforcano R, Nandy K (1979) Marked alterations in responsivity to psycho-stimulation and cholingergic drugs associated with senescence in the female mouse. Soc Neurosci Abstr 5, p 7Google Scholar
  108. 108.
    Landfield PW, Lynch G (1977) Impaired monosynaptic potentation in in vitro hippocampal slices from aged, memory-deficient rats. J Gerontol 32, p 523PubMedGoogle Scholar
  109. 109.
    Landfield PW, McGaugh JL, Lynch G (1978) Impaired synaptic potentation processes in the hippocampus of aged, memory-deficient rats. Brain Res 150, p 85PubMedCrossRefGoogle Scholar
  110. 110.
    Lee T, Seeman P, Rajput A, Farley IJ, Hornykiewicz O (1978) Receptor basis for dopaminergic supersensitivity in Parkinson’s disease. Nature 273, p 59PubMedCrossRefGoogle Scholar
  111. 111.
    Lippa AS, Critchett DJ, Ehlert F, Yamamura HI, Enna SJ, Bartus RT (1981) Age-related alterations in neurotransmitter receptors: An electrophysiological and biochemical analysis. Neurobiol Aging 2, p 3PubMedCrossRefGoogle Scholar
  112. 112.
    Lippa AS, Pelham RW, Beer B, Critchett DJ, Dean RL, Bartus RT (1980) Brain cholinergic dysfunction and memory in aged rats. Neurobiol Aging 1, p 13PubMedCrossRefGoogle Scholar
  113. 113.
    Lloyd KG, Drekser S, Bird ED (1977) Alterations in 3H-GABA binding in Huntington’s chorea. Life Sci 21, p 747PubMedCrossRefGoogle Scholar
  114. 114.
    Lofstrom AP, Eneroth J A, Gustafsson J A, Skett P (1977) Effect of estradiol benzoate on catecholamine levels and turnover in discrete areas of the median eminence and the limbic forebrain, and on serum LH, FSH, and prolactin concentrations in the ovariectomized female rat. Endocrinology 101, p 1559CrossRefGoogle Scholar
  115. 115.
    Maggi A, Schmidt MJ, Shetti B, Enna SJ (1979) Effect of aging on neurotransmitter receptor binding in rat and human brain. Life Sci 24; p 367PubMedCrossRefGoogle Scholar
  116. 116.
    Makman MH, Ahn HS, Thai LJ, Dvorkin B, Horowitz SG, Sharpless NS, Rosenfeld M (1978) Decreased brain biogenic amine-stimulated adenylate cyclase and spiroperidol-bind- ing sites with aging. Fed Proc 37, p 548Google Scholar
  117. 117.
    Makman MH, Ahn HS, Thai LJ, Sharpless NS, Dvorkin B, Horowitz SG, Rosenfeld M (1980) Evidence for selective loss of brain dopamine and histamine-stimulated adenylate cyclase activities in rabbits with aging. Brain Res 192, p 177PubMedCrossRefGoogle Scholar
  118. 118.
    Marwaha J, Hoffer BJ, Freedman R (1981) Changes in noradrenergic neurotransmission in rat cerebellum during aging. Neurobiol Aging 2, p 95PubMedCrossRefGoogle Scholar
  119. 119.
    Marwaha J, Hoffer BJ, Pittman R, Freedman R (1980) Age-related electrophysiological changes in rat cerebellum. Brain Res 201, p 85PubMedCrossRefGoogle Scholar
  120. 120.
    McGeer EG, Fibiger HC, McGeer PL, Wickson V (1971) Aging and brain enzymes. Exp Gerontol 6, p 391PubMedCrossRefGoogle Scholar
  121. 121.
    McGeer EG, McGeer PL (1975) Age changes in the human for some enzymes associated with metabolism of catecholamines, GABA, and acetylcholine. In: Ordy JM, Brizzee KR (eds) Neurobiology of aging. Plenum Press, New York, p 287Google Scholar
  122. 122.
    McGeer EG, McGeer PL (1976) Neurotransmitter metabolism and the aging brain. In: Terry RD, Gershon S (eds) Neurobiology of aging. Raven Press, New York, p 389Google Scholar
  123. 123.
    McGeer PL, McGeer EG (1978) Aging and neurotransmitter systems. In: Finch CE, Potter DE, Kenny AD (eds) Parkinson’s disease-II. Aging and neuroendocrine relationships. Plenum Press, New York, p 41Google Scholar
  124. 124.
    McGeer PL, McGeer EG (1976) Enzymes associated with the metabolism of catecholamines, acetylcholine and GABA in human controls and patients with Parkinson’s disease and Huntington’s chorea. J Neurochem 26, p 65PubMedGoogle Scholar
  125. 125.
    McGeer PL, McGeer EG, Fibiger HC (1973) Glutamic acid decarboxylase and choline ace-tylase in Huntington’s chorea and Parkinson’s disease. Lancet 11: 623CrossRefGoogle Scholar
  126. 126.
    McNamara ML, Cooper RL (1979) Age differences in conditioned taste aversion: Possible role of vasopressin. Soc Neurosci Abstr 5, p 8Google Scholar
  127. 127.
    Meek JL, Bertilsson L, Cheney DL, Zsilla G, Costa E (1977) Aging-induced changes in acetylcholine and serotonin content of discrete brain nuclei. J Gerontol 32, p 129Google Scholar
  128. 128.
    Meier-Ruge W, Reichlmeier K, Iwangoff P (1976) Enzymatic and enzyme histochemical changes of the aging animal brain and consequences for experimental pharmacology of aging. In: Terry RD, Gershon S (eds) Neurobiology of aging. Raven Press, New York, p 379Google Scholar
  129. 129.
    Messing RB, Vasquez BJ, Samaniego B, Jensen RA, Martinez J, McGaugh JL (1981) Alterations in dihydromorphine binding in cerebral hemispheres of aged male rats. J Neuro- chem 36, p 784Google Scholar
  130. 130.
    Messing RB, Vasquez BJ, Spiehler VR, Martinez JL, Jensen RA, Rigter H, McGaugh JL (1980) 3H-dihydromorphine binding in brain regions of young and aged rats. Life Sei 26, p 921CrossRefGoogle Scholar
  131. 131.
    Miller NE, Cohen GD (eds) (1981) Clinical aspects of Alzheimer’s disease and senile dementia. Raven Press, New YorkGoogle Scholar
  132. 132.
    Miller AE, Shaar CJ, Riegle GD (1976) Aging effects on hypothalamic dopamine and norepinephrine content in the male rat. Exp Aging Res 2, p 475PubMedCrossRefGoogle Scholar
  133. 133.
    Misra CH, Shelat HS, Smith RC (1980) Effect of age on adrenergic and dopaminergic receptor binding in rat brain. Life Sei 27, p 521CrossRefGoogle Scholar
  134. 134.
    Mohs RC, Davis KL, Tinklenberg JR, Hollister LE (1980) Choline chloride effects on memory in the elderly. Neurobiol Aging 1, p 21PubMedCrossRefGoogle Scholar
  135. 135.
    Mohs RC, Davis KL, Tinklenberg JR, Hollister LE, Yesavage JA, Kopell BS (1979) Choline chloride treatment of memory deficits in the elderly. Am J Psychiat 136, p 1275PubMedGoogle Scholar
  136. 136.
    Morin AM, Wasterlain CG (1980) Aging and rat brain muscarinic receptors as measured by quinuclidinyl benzilate binding. Neurochem Res 5, p 301PubMedCrossRefGoogle Scholar
  137. 137.
    Moss DE, Deutsch JA (1975) Cholinergic mechanisms and memory. In: Waser PG (ed) Cholinergic mechanisms. Raven Press, New York, p 483Google Scholar
  138. 138.
    Muramoto O, Sugishita M, Sugota H, Toyokura Y (1979) Effect of physostigmine on constructional and memory tasks in Alzheimer’s disease. Arch Neurol 36, p 501PubMedGoogle Scholar
  139. 139.
    Nandy K (1981) Morphological changes in the cerebellar cortex of aging Macaca nemes-trina. Neurobiol Aging 2, p 61PubMedCrossRefGoogle Scholar
  140. 140.
    Neff NH, Yang HT, Fuentes JA (1974) The use of selective MAO inhibitory drugs to modify amine metabolism in brain. In: Usdin E (ed) Neuropsychopharmacology of the monoamines and their regulatory enzymes. Raven Press, New YorkGoogle Scholar
  141. 141.
    Nelson FJ, Latham KR, Finch CE (1975) Plasma testosterone levels in C57BL/6J mice: Effects of age and disease. Acta Endocrinol 80, p 744PubMedGoogle Scholar
  142. 142.
    Nies A, Robinson DS, Davis JM et al. (1973) Changes in MAO with aging. In: Eisdorfer C, Fann WE (eds) Psychopharmacology and aging. Plenum Press, New York, p 41Google Scholar
  143. 143.
    Ordy JM, Scheide OA (1973) Univariate and multivariate models for evaluating long-term changes in neurobiological development, maturity, and aging. In: Ford DH (ed) Prog, in brain res., vol 40: Neurobiol aspects of maturation and aging. Elsevier, Amsterdam, p 25CrossRefGoogle Scholar
  144. 144.
    Osterburg HH, Donahue HG, Severson IA, Finch CE (1981) Catecholamine levels and turnover during aging in brain regions of male C57BL/6J mice. Brain Res 224, p 337PubMedCrossRefGoogle Scholar
  145. 145.
    Ostfeld AM, Gibson DC (1972) Epidemiology of aging. U.S. Government Printing Office, Washington D.C.Google Scholar
  146. 146.
    Papavasiliou PS, Miller ST, Thal LJ, Nerder LJ, Houlihan G, Rao SN, Stevens JM (1981) Age-related motor and catecholamine alterations in mice on L-DOPA-supplemented diet. Life Sei 28, p 2947CrossRefGoogle Scholar
  147. 147.
    Pedigo NW, Schoemaker H, Morelli M, McDougal JN, Malick JB, Burks TF, Yamamura HI (1981) Benzodiazepine receptor binding in young, mature and senescent rat brain and kidney. Neurobiol Aging 2, p 83PubMedCrossRefGoogle Scholar
  148. 148.
    Perry EK, Perry RH, Blessed G, Tomlinson BE (1977) Necropsy evidence of central cholinergic deficits in senile dementia. Lancet 1: 189PubMedCrossRefGoogle Scholar
  149. 149.
    Perry EK, Gibson PH, Blessed G, Perry RH, Tomlinson BF (1977) Neurotransmitter enzyme abnormalities in senile dementia. J Neurol Sei 34, p 247CrossRefGoogle Scholar
  150. 150.
    Perry EK (1980) The cholinergic system in old age and Alzheimer’s disease. Age Ageing 9, p 1PubMedCrossRefGoogle Scholar
  151. 151.
    Perry EK, Perry RH, Blessed G, Gibson PH, Tomlinson BE (1977) A cholinergic connection between normal ageing and senile dementia in the human hippocampus. Neurosci Lett 6, p 85PubMedCrossRefGoogle Scholar
  152. 152.
    Perry EK, Blessed G, Tomlinson BE, Perry RH, Crow TJ, Cross AJ, Dockray GJ, Dimaline R, Aggregui A (1981) Neurochemical activities in human temporal lobe related to aging and Alzheimer-type changes. Neurobiol Aging 2, p 251PubMedCrossRefGoogle Scholar
  153. 153.
    Peters BH, Leving HS (1978) Effects of physostigmine and lecithin on memory in Alzheimer’s disease. Ann Neurol 6, p 219CrossRefGoogle Scholar
  154. 154.
    Pittman RN, Minneman K, Molinoff PB (1980) Alterations in a- and β-adrenergic receptor density in the cerebellum of aging rats. J Neurochem 35, p 273PubMedCrossRefGoogle Scholar
  155. 155.
    Plaitakis A, Berl S, Yahr MD (1982) Abnormal glutamate metabolism in an adult-onset degenerative neurological disorder. Science 216, p 193PubMedCrossRefGoogle Scholar
  156. 156.
    Ponzio F, Brunello N, Algeri S (1978) Catecholamine synthesis in brain of aging rats. J Neurochem 30, p 1617PubMedCrossRefGoogle Scholar
  157. 157.
    Porta EA, Nitta RT, Nguyen L (1980) Effects of dietary fat, vitamin E, and aging on cerebellar Purkinje cells of the rat. Fed Proc 39, p 500Google Scholar
  158. 158.
    Prange AJ, White JE, Lipton MA, Kindead MA (1967) Influence of age on MAO and catechol-O-methyl transferase in rat tissues. Life Sci 6, p 581PubMedCrossRefGoogle Scholar
  159. 159.
    Price MT, Olney JW, Haft R (1981) Age-related changes in glutamate concentration and synaptosomal glutamate uptake in adult rat striatum. Life Sci 28, p 1365PubMedCrossRefGoogle Scholar
  160. 160.
    Puri SK, Volicer L (1977) Effects of aging on cyclic AMP levels and adenylate cyclase and phosphodiesterase activities in the rat corpus striatum. Mech Ageing Develop 6, p 53CrossRefGoogle Scholar
  161. 161.
    Randall PK, Severson J A, Finch CE (1981) Aging and the regulation of striatal dopaminergic mechanisms in mice. J Pharm Exp Ther 219, p 695Google Scholar
  162. 162.
    Reis DJ, Ross RA, Joh TH (1977) Changes in the activity and amounts of enzymes synthesizing catecholamines and acetylcholine in brain, adrenal medulla, and sympathetic ganglia of aged rat and mouse. Brain Res 136, p 465PubMedCrossRefGoogle Scholar
  163. 163.
    Reisine TD, Beaumont K, Bird ED, Spokes E, Yamamura HI (1979) Huntington’s disease: Alterations in neurotransmitter receptor binding in the human brain. In: Barbeau A, Chase T, Paulson GW (eds) Advances in neurology, vol 23: Huntington’s disease. Raven Press, New York, p 717Google Scholar
  164. 164.
    Reisine TD, Pedigo NW, Meiners C, Iqbal K, Yamamura HI (1980) Alzheimer’s disease: Studies on neurochemical alterations in the brain. In: Amaducci L, Davison AN, Antuono P (eds) Aging of the brain and dementia. Raven Press, New York, p 147Google Scholar
  165. 165.
    Riederer P, Wuketich ST (1976) Time course of nigrostriatal degeneration in Parkinson’s disease. J Neural Transm 38, p 277PubMedCrossRefGoogle Scholar
  166. 166.
    Robinson DS (1975) Changes in MAO and monoamines with human development and aging. Fed Proc 34, p 103PubMedGoogle Scholar
  167. 167.
    Robinson DS, Nies A, Davis JN, Bunney WE, Davis JM, Colburn RW, Bourne HR, Shaw DM, Coppen AJ (1972) Aging, monoamines and MAO levels. Lancet 1: 290PubMedCrossRefGoogle Scholar
  168. 168.
    Robinson DS, Sourkes RL, Nies A, Harris LS, Spector S, Bartlett DL, Kaye IS (1977) Monoamine metabolism in human brain. Arch Gen Psychiat 34, p 89PubMedGoogle Scholar
  169. 169.
    Rogers J, Zoraetzer SF, Bloom FE (1981) Senescent pathology of cerebellum: Purkinje neurons and their parallel fiber afferents. Neurobiol Aging 2, p 15PubMedCrossRefGoogle Scholar
  170. 170.
    Rogers J, Silver MA, Shoemaker WJ, Bloom FE (1980) Senescent changes in a neurobio-logical model system: Cerebellar Purkinje cell electrophysiology and correlative anatomy. Neurobiol Aging 1, p 3PubMedCrossRefGoogle Scholar
  171. 171.
    Rogers J, Zornetzer SF, Shoemaker WJ, Bloom FE (1981) Electrophysiology of aging brain: Senescent pathology of cerebellum. In: Enna SJ, Samorajski T (eds) Brain neurotransmitters and receptors in aging and age-related disorders. Raven Press, New York, p 81Google Scholar
  172. 172.
    Roubein IF, Embree LJ, Kay D, Jackson DJ (1981) Aging effect on biogenic amines in rat hippocampus. Age 4, p 144Google Scholar
  173. 173.
    Samorajski T, Rolsten C (1973) Age and regional differences in the chemical composition of brains of mice, monkeys, and humans. In: Ford DH (ed) Progress in brain res, vol 40: Neurobiological aspects of maturation and Aging. Elsevier, Amsterdam, p 251Google Scholar
  174. 174.
    Samorajski T, Rolsten C, Ordy JM (1971) Changes in behavior, brain and neuroendocrine chemistry with age and stress in C57BL/10 male mice. J Gerontol 26, p 168PubMedGoogle Scholar
  175. 175.
    Sastry BV, Janson VE, Jaiswal N, Tayeb OS (1981) Deficiencies in the cholinergic nervous system of the rat cerebrum as a function of age. Age 4, p 142Google Scholar
  176. 176.
    Schmidt MJ (1981) The cyclic nucleotide system in the brain during aging. In: Enna SJ, Samorajski T, Beer B (eds) Brain neurotransmitters and receptors in aging and age-related disorders. Raven Press, New York, p 171Google Scholar
  177. 177.
    Schmidt MJ, Thornberry JF (1978) Cyclic AMP and cyclic GMP accumulation in vitro in brain regions of young, old, and aged rats. Brain Res 139, p 159CrossRefGoogle Scholar
  178. 178.
    Schocken DD, Roth GS (1977) Reduced beta-adrenergic receptor concentrations in ageing man. Nature 267, p 856PubMedCrossRefGoogle Scholar
  179. 179.
    Segal PE, Miller C, Timiras PS (1975) Abstr 10th Cong Gerontol 2, p 33Google Scholar
  180. 180.
    Severson JA, Finch CE (1980) Age changes in human basal ganglion dopamine receptors. Fed Proc 39, p 508Google Scholar
  181. 181.
    Severson JA, Finch CE (1980) Reduced dopaminergic binding during aging in the rodent striatum. Brain Res 192, p 147PubMedCrossRefGoogle Scholar
  182. 182.
    Sherman KA, Dallob A, Dean RL, Bartus RT, Friedman E (1980) Neurochemical and behavioral deficit in aging rats. Fed Proc 39, p 508Google Scholar
  183. 183.
    Sherman KA, Friedman E, Bartus RT (1981) Presynaptic cholinergic mechanisms in brains of aged, memory impaired Fisher 344 rats. Age 4, p 142Google Scholar
  184. 184.
    Shih JC, Young H (1978) The alteration of serotonin binding sites in aged human brain. Life Sei 23, p 1441CrossRefGoogle Scholar
  185. 185.
    Siakatos AN, Armstrong D (1976) Advances in behavioral biology, vol 16, In: Ordy JM, Brizzee KR (eds). Plenum Press, New York, p 369Google Scholar
  186. 186.
    Simpkins JW, Mueller GP, Huang HH, Meites J (1977) Evidence for depressed catecholamine and enhanced serotonin metabolism in aging male rats: Possible relation to gondo-tropin secretion. Endocrinology 100, p 1672PubMedCrossRefGoogle Scholar
  187. 187.
    Sims KL, Bloom FE (1973) Rat brain 3,4-dihydroxyphenylalanine and 5-hydroxytrypto- phan decarboxylase activities: Differential effects of 6-hydroxydopamine. Brain Res 49, p 165PubMedCrossRefGoogle Scholar
  188. 188.
    Sitaram N, Weingartner H, Gillin JC (1978) Human serial learning: enhancement with are-choline and choline and impairment with scopolamine. Science 201, p 274PubMedCrossRefGoogle Scholar
  189. 189.
    Sladek CD, McNeill TH, Gregg CM, Blair ML, Baggs RB (1981) Vasopressin and renin response to dehydration in aged rats. Neurobiol Aging 2, p 293PubMedCrossRefGoogle Scholar
  190. 190.
    Smith AM, Swash M (1979) Physostigmines in Alzheimer’s disease. Lancet 1: 42PubMedCrossRefGoogle Scholar
  191. 191.
    Smith RC, Shelat HS, Sammeta J, Misra CH (1981) Aging, receptors and neuroleptic drugs. In: Enna SJ, Samorajski T, Beer B (eds) Aging, vol 17: Brain Neurotransmitters and receptors in aging and age-related disorders. Raven Press, New York, p 231Google Scholar
  192. 192.
    Spokes GS (1979) An analysis of factors influencing measurements of dopamine, noradrenaline, glutamate decarboxylase and choline acetylase in human postmortem brain tissue. Brain 120, p 333CrossRefGoogle Scholar
  193. 193.
    Steger RW, Sonntag WE, Van Vugt DA, Forman LJ, Meites J (1980) Reduced ability of naloxone to stimulate LH and testosterone release in aging male rats; possible relation to increase in hypothalamic met5-enkephalin. Life Sei 27, p 747CrossRefGoogle Scholar
  194. 194.
    Storer JB (1969) Longevity and gross pathology at death in 22 inbred mouse strains. J Gerontol 21, p 404Google Scholar
  195. 195.
    Storm-Mathisen J (1976) Distribution of the components of the GABA system in neuronal tissue: cerebellum and hippocampus. In: Roberts E, Chase TN, Tower DB (eds) GABA in nervous system function. Raven Press, New York, p 149Google Scholar
  196. 196.
    Storm-Mathiesen J (1977) Localization of transmitter candidates in the brain: The hippo- campal formation as a model. Prog Neurobiol 8, p 119CrossRefGoogle Scholar
  197. 197.
    Stramentinoli G, Gualano M, Catto E, Algeri S (1977) Tissue levels of S-adenosylmethio- nine in aging rats. J Gerontol 32, p 392PubMedGoogle Scholar
  198. 198.
    Strong R, Hicks P, Hsu L, Bartus RT, Enna SJ (1980) Age-related alterations in the rodent brain cholinergic system and behavior. Neurobiol Aging 1, p 59PubMedCrossRefGoogle Scholar
  199. 199.
    Strong R, Hsu L, Hicks P, Enna SJ (1979) Age-related decrease in mouse brain cholinergic muscarinic receptor binding. Soc Neurosci Abstr 5, p 11Google Scholar
  200. 200.
    Sun AY (1976) Aging and in vivo norepinephrine-uptake in mammalian brain. Exp Aging Res 2, p 207PubMedCrossRefGoogle Scholar
  201. 201.
    Thai LJ, Horowitz SG, Dvorkin B, Makman MH (1980) Evidence for loss of brain [3H]spiroperidol and [3H]ADTN binding sites in rabbit brain with aging. Brain Res 192, p 185CrossRefGoogle Scholar
  202. 202.
    Timiras PS, Vernadakis A (1972) Structural, biochemical, and functional aging of the nervous system. In: Timiras PS (ed) Developmental physiology and aging. Macmillan, New York, p 502Google Scholar
  203. 203.
    Timaras PS, Hudson DB, Oklund S (1973) Changes in CNS free amino acids with development and aging. In: Ford DH (ed) Progress in brain research, vol 40: Neurobiological aspects of maturation and aging. Elsevier, Amsterdam, p 267CrossRefGoogle Scholar
  204. 204.
    Turkington MR, Everitt AV (1976) The neurohypophysis and aging with special reference to the antidiuretic hormone. In: Everitt AV, Burgess J A, Charles C (eds)Hypothalamus, pituitary and aging. Thomas, Springfield, III, p 123Google Scholar
  205. 205.
    Unsworth BR, Fleming LH, Caron PC (1980) Neurotransmitter enzymes in telencephalon, brain stem, and cerebellum during the entire life span of the mouse. Mech Ageing Develop 13, p 205CrossRefGoogle Scholar
  206. 206.
    Vernadakis A (1973) Comparative studies of neurotransmitter substances in the maturing and aging CNS of the chicken. In: Ford DH (ed) Progress in brain research, vol 40: Neurobiological aspects of maturation and aging. Elsevier, Amsterdam, p 341Google Scholar
  207. 207.
    Verzar F (1961) The age of the individual as one of the parameters of pharmacological action. Acta Physiol Acad Sci Hungary 19, p 313Google Scholar
  208. 208.
    Vijayan VK (1977) Cholinergic enzymes in the cerebellum and the hippocampus of the senescent mouse. Exp Gerontol 12, p 7PubMedCrossRefGoogle Scholar
  209. 209.
    Vijayashankar N, Brody H (1979) A quantitative study of the pigmented neurons in the nuclei locus coeruleus and subcoeruleus in man as related to aging. J Neuropathol Exp Neurol 38, p 490PubMedCrossRefGoogle Scholar
  210. 210.
    Walker JB, Walker JP (1973) Properties of adenylate cyclase from senescent rat brain. Brain Res 54, p 391PubMedCrossRefGoogle Scholar
  211. 211.
    Waller SB, Ingram DK, Reynolds MA, London ED (1981) Changes in neurotransmitter synthetic enzymes as a function of genotype and age. Age 4, p 143Google Scholar
  212. 212.
    Wastek GJ, Stern LZ, Johnson PC, Yamamura HI (1976) Huntington’s disease: Regional alteration in muscarinic cholinergic receptor binding in human brain. Life Sci 19, p 1033PubMedCrossRefGoogle Scholar
  213. 213.
    Weiner RI, Ganong WF (1978) Role of brain monoamines and histamine in regulation of anterior pituitary secretion. Physiol Rev 58, p 905PubMedGoogle Scholar
  214. 214.
    Wheeler DD (1980) Aging of membrane transport mechanisms in the CNS. High-affinity glutamic acid transport in rat cortical synaptosomes. Exp Gerontol 15, p 269PubMedCrossRefGoogle Scholar
  215. 215.
    White P, Hiley CR, Goodhardt MJ, Carrasco LH, Keet JP, Williams IEI, Bowen DM (1977) Neocortical cholinergic neurons in elderly people. Lancet 1: 668PubMedCrossRefGoogle Scholar
  216. 216.
    Wree A, Braak H, Schleicher A, Zilles K (1980) Biomathematical analysis of the neuronal loss in the aging human brain of both sexes, demonstrated in pigment preparations of the pars cerebellaris locus eoerulei. Anat Embryol 160, p 105PubMedCrossRefGoogle Scholar
  217. 217.
    Yamamura HI (1981) Neurotransmitter receptor alterations in age-related disorders. In: Enna SJ, Samorajski T, Beer B (eds) Brain neurotransmitters and receptors in aging and age-related disorders. Raven Press, New York, p 143Google Scholar
  218. 218.
    Yates CM, Simpson J, Maloney AFJ, Gordon A, Reid AH (1980) Alzheimer-like cholinergic deficiency in Down syndrome. Lancet 11: 979CrossRefGoogle Scholar
  219. 219.
    Zimmerman ID, Berg AP (1975) Phosphodiesterase and adenyl-cyclase activities in the cerebral cortex of the aging rat. Mech Ageing Develop 4, p 89CrossRefGoogle Scholar
  220. 220.
    Zornetzer SF, Bloom FE, Mervis R, Rogers J (1981) Senescent changes in balance, coordination, and cerebellar microanatomy. Neurosci Abstr 7, p 690Google Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1986

Authors and Affiliations

  • J. Rogers
  • W. J. Shoemaker
  • F. E. Bloom
    • 1
  1. 1.The Salk InstituteSan DiegoUSA

Personalised recommendations